IP Library Granted Patent US 8,375,730
Granted Patent B2
US 8,375,730 · App. 13/358,662 · Granted Feb 19, 2013

Selecting packaging and coolant systems for shipment of biological products

Inventors: Klaus H. Haarmann (Frisco, TX); Anthony Alleva (Keansburg, NJ); Eric Paul Mirabel (Houston, TX)
Assignee: TCP Reliable, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,375,730
App. No.
13/358,662
Granted
Feb 19, 2013
Kind
B2
Abstract

Disclosed is a process of selecting of a container and temperature-control system, such that biological products (including blood) requiring maintenance within a specified range of temperatures are so maintained during shipment. The process requires a prediction of the maximum period of shipment, and the predicted ambient temperature ranges and time of exposure thereto for the system during the period of shipment. With that information, a system of container(s) with temperature-control agents including dry ice, ice, frozen gel packs or a phase change material, is selected.

Claims (23)

1. A process of ensuring blood for transfusion requiring temperature-control is maintained within a range of 22° C.±2° C. during shipment, comprising:

determining the maximum predicted period of shipment for the blood and the predicted ambient temperature ranges during shipment;

establishing a database for a plurality of temperature-control systems, each system including containers and a phase change material within the containers wherein the database can be used to determine the length of time each member system can maintain blood housed in the containers with the phase change material within said range when the temperature-control system is exposed to specified ranges of ambient temperatures for specified time periods, and wherein the specified ranges and time periods can represent, respectively, the predicted ambient temperature ranges and times of exposure thereto for the member system during said maximum total predicted period of shipment;

selecting a system of containers and a phase change material so that the blood is expected to be maintained within said range during the maximum predicted period of shipment at the predicted ambient temperature ranges;

monitoring the system temperature to determine directly if it stays within a specified range or monitoring the ambient temperature and determining, by derivation, if the system temperature stays within the specified range such that the blood is maintained within said range;

alerting an operator if the system temperature is outside the specified range, whereby pursuant to the alert, the operator takes or directs actions to bring the system temperature within the specified range; and

testing the blood using a blood-typing assay wherein, in the course of the assay, there is one or more of: nucleic acid hybridization, nucleic acid chain elongation, antibody-protein binding, or protein-protein binding wherein the relative humidity, pressure, and CO 2 is also monitored during shipment.

2. The process of claim 1 wherein the database is established on a computer and the selection of a member system is performed as an algorithm executed by the computer.

3. The process of claim 1 wherein the systems further include dry ice, ice, or frozen gel packs.

4. The process of claim 1 wherein the database is established by deriving, from the characteristics of the containers and the phase change material, the length of time each member system can maintain products housed in the containers with the phase change material within a specified range of temperatures when the member system is exposed to specified ranges of ambient temperatures for specified time periods.

5. The process of claim 1 wherein the system selected is one which minimizes the use of the phase change material.

6. The process of claim 1 wherein the selection can be performed from a remote location through a web-based system allowing computer access.

7. The process of claim 1 wherein the system(s) selected and their price(s) are displayed in operator-readable form.

8. The process of claim 7 wherein the database also includes the shippers charges for different shipment options to a particular destination, and the alogrithm also determines the lowest-cost combination of system and shippers' charges to said destination.

9. The process of claim 1 wherein the predicted ambient temperature range is from the lowest ambient temperature likely to be experienced to the highest, and the predicted time period a member system is to be exposed to said predicted ambient temperature range is the entire length of the shipment period.

10. The process of claim 1 wherein the blood is in blood bags.

11. The process of claim 1 wherein the predicted ambient temperature range for the system during shipment is based on historic ambient temperature data for the predicted shipping route.

12. The process of claim 11 wherein ambient temperature data is monitored during shipment and alerts indicate excursions from the predicted ambient temperature range.

13. The process of claim 1 wherein the container is made of expanded polystyrene or polyethylene.

14. The process of claim 1 further including obtaining a warranty for delivery within the shipment period from a shipper.

15. The process of claim 1 wherein the system is in a temperature-controlled environment during shipment.

16. The process of claim 1 further including recording the temperatures monitored.

17. The process of claim 1 wherein the temperatures monitored are used in determining the predicted ambient temperature for blood shipped in the future.

Assignments (9)
SECURITY INTEREST Recorded Dec 10, 2025
From: NEXKEMIA PETROCHEMICALS INC.; INTEGREON GLOBAL, INC.; CRYOPAK INDUSTRIES INC.; CRYOPAK VERIFICATION TECHNOLOGIES, INC.; DDL, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 073180/0930 →
CHANGE OF NAME Recorded Mar 22, 2023
From: TCP RELIABLE, INC.
To: INTEGREON GLOBAL, INC.
Reel/Frame 063141/0543 →
CHANGE OF NAME OF OWNER Recorded Nov 28, 2022
From: TCP RELIABLE, INC.
To: INTEGREON GLOBAL, INC.
Reel/Frame 063083/0353 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY ADDRESS PREVIOUSLY RECORDED AT REEL: 043120 FRAME: 0559. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Sep 20, 2017
From: TCP RELIABLE, INC.; TCP RELIABLE MANUFACTURING, INC.; CRYOPAK INDUSTRIES (2007) ULC; CRYOPAK VERIFICATION TECHNOLOGIES, INC.; DDL, INC.; NEXKEMIA PETROCHEMICALS INC.
To: ROYAL BANK OF CANADA
Reel/Frame 043919/0280 →
SECURITY INTEREST Recorded Jul 27, 2017
From: TCP RELIABLE, INC.; TCP RELIABLE MANUFACTURING, INC.; CRYOPAK INDUSTRIES (2007) ULC; CRYOPAK VERIFICATION TECHNOLOGIES, INC.; DDL, INC.; NEXKEMIA PETROCHEMICALS INC.
To: ROYAL BANK OF CANADA
Reel/Frame 043120/0559 →
SECURITY INTEREST Recorded Aug 25, 2016
From: CRYOPAK INDUSTRIES (2007) ULC; NEXKEMIA PETROCHEMICALS INC.; TCP RELIABLE, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 039543/0537 →
SECURITY INTEREST Recorded Apr 29, 2016
From: TCP RELIABLE, INC.
To: BDC CAPITAL INC.
Reel/Frame 038428/0032 →
SECURITY INTEREST Recorded Jun 5, 2015
From: TCP RELIABLE MANUFACTURING, INC.
To: ROYAL BANK OF CANADA
Reel/Frame 035834/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2012
From: THIBAULT, LOUIS; HAARMANN, KLAUS; ALLEVA, ANTHONY; BEAUSEJOUR, ANNIE; TREMBLAY, MARIO; LAPOINTE, SERGHE; BARAKAT, MAURICE
To: TCP RELIABLE, INC.
Reel/Frame 028344/0973 →
Continuity (3)
Continuation In Part 13274593 · Oct 17, 2011
Provisional Application 61437555 · Jan 28, 2011
Related Publication 20120197810A1 · Aug 2, 2012